伊尼妥单抗-三生制药.pdf

三生制药2018年度业绩投资者演示材料 2019 年 3 月 21 日 免责声明 This document has been prepared by 3SBio Inc. (the Company) solely for selected recipients for information purposes only. You must read the terms, conditions, limitations, notifications, restrictions, acknowledgments and representations in the fol lowing (collectively, the Terms) before reading or making any other use of this document. In accepting the delivery of, reading or making any other use of this document, you acknowledge and agree to be bound by the Terms, and you agree to maintain absolute confidentiality regarding the information disclosed in this document in a manner consistent with the Terms. If you do not accept any of the Terms, in whole or in part, please immediately return this document to the Company. These materials, and any further information made available to you, are highly confidential and are being given solely for yo ur information. These materials, and any further information made available to you, form part of the proprietary information of the Company and may not be copied, reproduced, redistributed or passed on, directly or indirectly, to any other person (whether within or outside your o rganization/firm) or published or otherwise disclosed, in whole or in part, in any manner and for any purpose without the prior written consent from the Company. Any forwarding, distribution or reproduction of this document, in whole or in part, is unauthorized. The information used in preparing this document has not been independently verified and has not been reviewed by any regulato ry authority in any jurisdiction. This document does not purport to provide a complete description of the matters to which it re lates. No representation, warranty or undertaking, express or implied, is or will be made or given by, and no responsibility or liability is or will be accepted by, any person (for the avoidance of doubt, including but not limited to, the Company and its affiliates, controlling persons,